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 SUMMARY 
 A study was conducted to examine broiler performance and carcass yield across 5 consecu-
tive commercial broiler flocks after the removal of roxarsone (ROX) and growth-promoting an-
tibiotics (GPA) from the feed. Over a 1-yr period, approximately 552,000 broilers were reared 
in 4 solid-walled, tunnel-ventilated houses, divided into 2 paired-house facilities, and were as-
signed 1 of 2 dietary treatments. The treated group received basal diets containing salinomycin, 
ROX, and GPA, whereas the control group received the same diets without ROX and GPA. 
Average BW were recorded for 200 sample birds/treatment per flock at 18, 35, and 48 d of age. 
Average BW, feed conversion, adjusted feed conversion, livability, and condemnation were cal-
culated at the completion of each flock. Coccidiosis lesion scores of 10 birds per treatment were 
recorded at 14, 21, 28, 35, and 42 d of age. Before birds were transferred to a commercial pro-
cessing plant, 280 birds/flock were randomly selected, weighed, and tagged for carcass yield 
analysis. Livability was significantly negatively affected by the removal of ROX and GPA. 
Coccidiosis lesion scores were not affected by the treatments. Tender yields showed significant 
improvement, whereas all other cuts were not affected by removal of ROX and GPA. 
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 DESCRIPTION OF PROBLEM 
 Over the past 60 yr, antibiotics and anti-
coccidial drugs have been used to improve per-
formance in agricultural animal production by 
reducing the burden of bacteria in the gastroin-
testinal tract [1–3]. The polyether ionophorous 
coccidiostats have been used extensively in 
broiler production for the control of coccidiosis 
[4]. Monensin and salinomycin (SAL) were ap-
proved for use in broiler feeds by the FDA in 
1971 and 1983, respectively, and have since be-
come the 2 drugs of choice for the prevention of 
coccidiosis [5]. These drugs achieve control by 
altering the permeability of protozoan cell mem-
branes for alkaline metal cations, thereby upset-
ting the osmotic balance [6]. Antibiotics can be 
used therapeutically to treat poultry diseases but 
are more commonly used in a prophylactic man-
ner. Since the approval of bacitracin methylene 
disalicylate (BMD) and virginiamycin (VIR), 
they have been included in poultry diets at sub-
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therapeutic levels for increased rate of gain and 
improved feed efficiency [5]. These antibiotics 
may also prevent the occurrence of the bacterial 
infection necrotic enteritis, caused by Clostridi-
um spp. [7]. Roxarsone (ROX), another feed ad-
ditive commonly used in broiler diets, is an ar-
senical drug used for improving BW gain, feed 
efficiency, and skin pigmentation [5]. Roxarsone 
is also approved to aid anticoccidials in the con-
trol of eimeria tenella oocysts [8]. Further field 
experience has demonstrated that ROX may be 
effective at suppressing salmonella and possi-
bly other enteric organisms that can lead to food 
safety hazards in meat products [9].
Although antibiotics and anticoccidials are 
effective in their own respect, overall intestinal 
health shows the greatest improvement when 
these products are used in combination in broiler 
diets. The combination of an ionophore, ROX, 
and an antibiotic in the starter and grower diets 
and an antibiotic alone in the withdrawal diet 
has become the industry standard [3]. Although 
monensin and SAL are approved only for con-
trol of coccidiosis, field experience has revealed 
that these drugs have an effect on controlling 
gram-positive bacteria; combining them with an 
antibiotic and ROX takes advantage of the syn-
ergism between these drugs [10].
Consumer pressure has forced the poultry 
industry worldwide to examine pathogen re-
sistance resulting from using feed additives on 
a continuous basis for prophylactic prevention 
of disease and improved performance [6, 11]. 
Concerns have arisen from the antimicrobial 
resistance to antibiotics used in animal feeds, 
possibly resulting in microbial resistance in 
human medicine. This led to the ban of antibi-
otic growth promoters by the European Union 
in 2006 and has led to the continuous decrease 
in use of antibiotics at subtherapeutic levels in 
the United States [1]. The objective of this study 
was to evaluate the effects on performance and 
yield by withdrawing antibiotic growth promot-




This study was conducted in 4 solid-walled, 
tunnel-ventilated commercial broiler houses, 
with dimensions of 43 ft wide and 500 ft long, 
located at the Stephen F. Austin State University 
Broiler Research Center. Each house was identi-
cal in feeding, water, and ventilation equipment. 
The 4 houses were divided into 2 paired-house 
facilities, with each paired-house facility receiv-
ing 1 of 2 treatments (treated or control group) 
consistently throughout the 5 consecutive 
flocks. For each flock, 27,600 straight-run broil-
er chicks were placed in each house at a stocking 
density of 0.78 ft2/bird. Multiple breeds of birds 
were placed throughout the trial, with the ma-
jority being Ross 708. At the hatchery, an equal 
number of chicks from the respective breeder 
flocks were randomly divided before placement 
in the paired-house facilities. Birds were reared 
to an average of 49 d under standard commercial 
industry practices. The same environmental and 
lighting regimens were used consistently from 
flock to flock. Birds received light for 23 h at an 
intensity of 3.0 footcandles for 7 d. From d 8 to 
21, the photoperiod was reduced to 12 h/d and 
the intensity was lowered to 0.10 footcandles. 
The photoperiod was increased 2 h each week 
for the remainder of the flock while the light 
intensity remained the same. Birds were placed 
on built-up litter from 5 previous flocks, and no 
clean pine shavings were added between flocks.
Feeding and Dietary Treatments
Birds were fed standard commercial corn- 
and soy-based diets formulated to meet the 
requirements of broilers chickens. Feeding 
phases consisted of a starter diet, grower diet, 
withdrawal diet I, and withdrawal diet II, with 
feed changes occurring at approximately 18, 
35, and 42 d, respectively. Feed and water were 
provided ad libitum via an automated feeding 
system and nipple drinkers. The treated group 
was fed a basal diet that included SAL (60.0 g/
ton of starter and grower diets), ROX (45.4 g/
ton of starter diet and 34.0 g/ton of grower diet), 
BMD (50.0 g/ton of starter diet and 25.0 g/ton 
of grower diet), VIR (10.0 g/ton of withdrawal 
diet I), and no SAL, BMD, ROX, or VIR (with-
drawal diet II). The control group was fed the 
same diets containing SAL (60.0 g/ton of starter 
and grower diets), with ROX, BMD, and VIR 
removed from all diets, respectively. Each flock 
received the same treatment over the course of 
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the study. Samples were taken from each batch 
of feed and analyzed to ensure that diets con-
tained the proper levels of coccidiostat, ROX, 
and antibiotics or the absence of ROX and an-
tibiotics.
Yield Study and Data
A yield study was conducted at the comple-
tion of each flock using a total of 280 birds 
from the 4 houses. At 48 d of age, 70 birds 
per house (35 males and 35 females) were ran-
domly selected from each house. Males were 
differentiated from females by their visually 
larger body size and larger combs. Each house 
was divided into five 100-ft sections, and 14 
birds (7 males and 7 females) were selected to 
ensure a uniform representation of the house. 
A numbered wing-tag was placed in the wing 
of each bird and the birds were individually 
weighed and data recorded. The birds were 
then removed from the house and placed in an 
isolation pen, where feed was removed for 12 
h before processing. Water was not removed 
from the birds until immediately before pro-
cessing. Each yield study was conducted at 
approximately 49 d of age. At the Stephen F. 
Austin State University Pilot Processing Fa-
cility, the birds were stunned and then bled by 
using a sharp knife to sever at least 1 carotid 
artery and jugular vein. The birds were then 
scalded, defeathered, and manually eviscer-
ated, with the head, neck, and feet being re-
moved and discarded. Carcasses were then cut 
into front and hind halves and were weighed 
along with the abdominal fat. The front halves 
were skinned, wings were removed, and breast 
fillet and tenders (pectoralis major and pec-
toralis minor muscles) were deboned, leav-
ing the frame (spine and rib cage). The hind 
halves were dissected to remove the drums 
and thighs, leaving the back. All parts were 
weighed individually and yields were calcu-
lated relative to final BW. Total white meat 
(breast fillet + tenders) and percentage of to-
tal white meat [(total white meat/BW) × 100] 
were later calculated.
The remaining broilers in the houses were 
taken to a processing plant and slaughtered in 
a commercial setting. Each paired-house treat-
ment group was removed, processed, and tracked 
through the plant separately.
Data Collected
For each flock of the trial, 200 randomly se-
lected birds (100 males and 100 females) were 
individually weighed for each treatment group 
on d 18, 35, and 48. Birds were selected equal-
ly (10 males and 10 females) from five 100-ft 
sections within each house to ensure uniform 
distribution. From the commercial processing 
data of the remaining chickens, average BW, 
feed conversion, adjusted feed conversion, liv-
ability, and condemnation were calculated for 
each paired-house treatment group. Coccidiosis 
lesion scores [12] of the duodenum, ileum, and 
ceca were recorded from 5 randomly selected 
birds per house at 14, 21, 28, 35, and 42 d of 
age. Performance and yield data were analyzed 
by using the GLM procedure of SAS software 
[13]. When significance between the treatments 
was observed (P < 0.05), means were separated 
by using the least squares means test with the 
PDIFF option of this procedure.
RESULTS AND DISCUSSION
Growth Performance
Table 1 shows the means of the treated and 
control groups for the 200 chickens that were 
weighed per treatment group at d 18, 35, and 48. 
At 18 d of age, the control group had an equal or 
higher average BW for each of the 5 flocks, with 
the difference for flock 2 being significant. The 
overall 5-flock cumulative average between the 
treatments was 0.02 kg, with no significant dif-
ference. On d 35, the control group had a higher 
average BW for each flock and a cumulative 
average differential of 0.02 kg, but the differ-
ence was not significant. The 5-flock cumula-
tive average BW between the treatments at 48 
d of age was equal; therefore, significance was 
not detected.
Table 2 shows the impact of removing ROX 
and GPA from the diet of broilers processed in 
a commercial processing plant. The data reflect 
an average of 54,000 broilers/treatment taken to 
market at approximately 49 d of age. The cumu-
lative average BW for the 5 flocks showed that 
the control group had an overall 0.01-kg higher 
average than the treated group, which was not 
significantly different. Engster et al. [14] dem-
onstrated that average BW was not adversely 
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affected by removal of GPA for approximately 
1 yr. This study suggests similar results because 
average BW was not adversely affected over the 
1-yr study period.
Actual feed conversion followed a trend sim-
ilar to average BW throughout the study. Cumu-
lative feed conversion across the 5 flocks of the 
treated group was 0.01 lower than for the control 
group, which was not statistically significant. 
Feed conversion was adjusted for a 5-lb bird and 
a 1,500-kcal (ME) diet with 7 weight/point of 
feed conversion. When adjusted feed conversion 
was averaged across the 5 flocks, both groups 
were equal and were not significantly different. 
Research has shown that broiler performance 
may not be negatively affected until after the 
first year without prophylactic drug use [14] 
and that the environmental conditions can have 
a large role in the success or failure of an enteric 
health medication program [15].
Table 3 shows the differences between the 
treatment groups for livability (%) and condem-
nation (%) of the paired-house groups at 49 d 
of age. Across the 5-flock study, livability was 
shown to be negatively affected by the omission 
of GPA and ROX from the diets. The treated 
group had a higher livability percentage for ev-
ery flock, and the cumulative average of 0.37% 
was statistically different when compared with 
the control group. Condemnation at the process-
JAPR: Research Report168
Table 1. Effect of removing growth-promoting antibiotics (GPA) and roxarsone (ROX) on the average BW of broilers 
at 18, 35, and 48 d of age1 
Flock2
Average BW,3 kg
18 d 35 d 48 d
Treated Control Treated Control Treated Control
1 (06/08/06 to 07/27/06) 0.60a 0.62a 1.75a 1.78a 2.65a 2.67a
2 (08/10/06 to 09/28/06) 0.48b 0.50a 1.74a 1.76a 2.74a 2.74a
3 (10/12/06 to 11/30/06) 0.48a 0.49a 1.84a 1.85a 2.73a 2.76a
4 (12/22/06 to 02/08/07) 0.53a 0.56a 1.80a 1.83a 2.78a 2.76a
5 (03/06/07 to 04/24/07) 0.48a 0.48a 1.80a 1.82a 2.81a 2.80a
Cumulative average (flocks 1 to 5) 0.51a 0.53a 1.79a 1.81a 2.74a 2.74a
a,bMeans between treatment groups without a common superscript are significantly different (P < 0.05).
1Diets: treated = basal diets with coccidiostat, ROX, and GPA; control = basal diets with coccidiostat.
2Placement date of flock to ending date of flock.
3Average BW of 200 randomly selected individual bird BW per treatment group.
Table 2. Effect of removing growth-promoting antibiotics (GPA) and roxarsone (ROX) on average BW, feed 
conversion, and adjusted feed conversion of broilers at 49 d of age1 
Flock2
Average BW3 (kg) FCR4 (g/g) Adjusted FCR5 (g/g) 
Treated Control Treated Control Treated Control
1 (06/08/06 to 07/27/06) 2.62 2.67 1.83 1.80 1.62 1.59
2 (08/10/06 to 09/28/06) 2.60 2.65 1.81 1.82 1.61 1.61
3 (10/12/06 to 11/30/06) 2.62 2.59 1.90 1.94 1.69 1.74
4 (12/22/06 to 02/08/07) 2.60 2.60 1.92 1.92 1.71 1.72
5 (03/06/07 to 04/24/07) 2.62 2.63 1.96 1.96 1.75 1.74
Cumulative average (flocks 1 to 5) 2.61a 2.62a 1.88a 1.89a 1.68a 1.68a
aMeans between treatment groups with a common superscript are not significantly different (P < 0.05).
1Diets: treated = basal diet with coccidiostat, ROX, and GPA; control = basal diet with coccidiostat.
2Placement date of flock to ending date of flock.
3Average BW of remaining broilers processed in a commercial setting.
4FCR = (lb of feed/lb of total BW).
5Adjusted to a 5-lb bird and 1,500 kcal with 7 weight/point of feed conversion.
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ing plant varied from flock to flock between the 
treatments throughout the study. The treated 
group had a lower cumulative condemnation 
percentage at 49 d of age, but was not signifi-
cantly different from the control group.
Coccidiosis Lesion Scores
Coccidiosis lesion scores were examined 
throughout the study to evaluate the effects of 
withdrawing ROX and GPA from the diets. Coc-
cidial lesions were similar between the treat-
ments from week to week, with the amount and 
severity of lesions increasing gradually across 
the 5 flocks for both treatments. Lesion scores 
between the 2 treatment groups were not affect-
ed by treatment (data not shown).
Yield Performance
Average BW of the birds selected and tagged 
for the yield study were not significantly differ-
ent for any of the flocks or when accumulated for 
the entire study. The control group had a 1,952-g 
average carcass weight, compared with a 1,933-
g average carcass weight for the treated group 
over the course of the study; this difference was 
not significant. After the carcasses were divided 
into front and hind halves and the abdominal fat 
pad was removed, there was no difference be-
tween the treatments for each carcass half.
Table 4 shows the yield of the breast fillet, 
tenders, and wings after the front half was dis-
sected into each of the respective parts. Breast 
yield was not significantly affected by the re-
moval of ROX and GPA throughout the course 
of the study. At the completion of the study for 
flock 2, the control group had an average tender 
yield of 108.86 g and was significantly different 
from the 98.43-g average yield for the treated 
group. The control treatment had a 2.27-g great-
er cumulative average for tenders at the comple-
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Table 3. Effect of removing growth-promoting antibiotics (GPA) and roxarsone (ROX) on broiler livability (%) and 
condemnation (%) at 49 d of age1 
Flock2
Livability3 (%) Condemnation4 (%)
Treated Control Treated Control
1 (06/08/06 to 07/27/06) 98.29 97.73 0.45 0.86
2 (08/10/06 to 09/28/06) 98.05 97.76 0.41 0.51
3 (10/12/06 to 11/30/06) 98.28 97.82 0.54 0.45
4 (12/22/06 to 02/08/07) 97.70 97.16 0.34 0.44
5 (03/06/07 to 04/24/07) 97.98 97.95 0.41 0.33
Cumulative average (flocks 1 to 5) 98.05a 97.68b 0.43a 0.52a
a,bMeans between treatment groups without a common superscript are significantly different (P < 0.05).
1Diets: treated = basal diets with coccidiostat, ROX, and GPA; control = basal diets with coccidiostat.
2Placement date of flock to ending date of flock.
3Livability (%) of remaining broilers processed in a commercial setting.
4Condemnation (%) of remaining broilers processed in a commercial setting.
Table 4. Effect of removing growth-promoting antibiotics (GPA) and roxarsone (ROX) on breast fillet, tender, and 
wing yield of broilers at 49 d of age1 
Flock2
Breast fillet (g) Tenders (g) Wings (g)
Treated Control Treated Control Treated Control
1 (06/08/06 to 07/27/06) 391.45a 404.60a 94.80a 96.62a 205.48a 206.38a
2 (08/10/06 to 09/28/06) 413.68a 439.53a 98.43b 108.86a 212.28b 221.81a
3 (10/12/06 to 11/30/06) 410.50a 412.32a 99.34a 102.51a 211.83a 211.83a
4 (12/22/06 to 02/08/07) 437.26a 420.03a 107.96a 102.97a 220.45a 214.10a
5 (03/06/07 to 04/24/07) 435.45a 435.00a 106.14a 106.14a 215.46a 210.47a
Cumulative average (flocks 1 to 5) 417.67a 422.29a 101.15b 103.42a 213.00a 213.00a
a,bMeans between treatment groups without a common superscript are significantly different (P < 0.05).
1Diets: treated = basal diets with coccidiostat, ROX and GPA; control = basal diets with coccidiostat.
2Placement date of flock to ending date of flock.
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tion of the study, which was significant. Average 
wing yield was significantly higher for the con-
trol group for flock 2, with an average of 221.81 
g, as compared with the treated group, with an 
average of 212.28 g. However, the cumulative 
average for the study was not statistically dif-
ferent between the 2 groups, with an average of 
213 g.
Table 5 shows the sum of breast fillet and 
tender yields as total white meat production for 
each group. By the end of the study, the removal 
of ROX and GPA had no effect on the yield of 
total white meat produced. The control group 
had a significantly higher percentage of total 
white meat related to BW for flock 2 (19.85%), 
as compared with the treated group (19.17%). 
The cumulative average across all flocks showed 
that the removal of ROX and GPA from the diet 
had no adverse effect on the percentage of total 
white meat produced.
The hind half was dissected to evaluate the 
drums, thighs, and back yield of the carcass. 
Drum yield was significantly higher for the con-
trol group for the first flock of the study, with a 
difference of 6.85 g over the treated group (Ta-
ble 6). Both treatments had an equal cumulative 
average yield for drums of 270.34 g and were 
therefore not significant. Thigh and back yields 
were not affected by removing ROX and GPA 
from flock to flock, or at the completion of the 
study.
CONCLUSIONS AND APPLICATIONS
 1.  Removal of ROX and GPA from the di-
ets of commercial broilers across 5 con-
secutive flocks showed no negative ef-
fects on broiler performance.
 2.  Feed conversion was not affected by the 
removal of ROX and GPA from the di-
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Table 5. Effect of removing growth-promoting antibiotics (GPA) and roxarsone (ROX) on total white meat and 
percentage of total white meat yield of broilers at 49 d of age1 
Flock2
Total white meat3 (g) Total white meat4 (%)
Treated Control Treated Control
1 (06/08/06 to 07/27/06) 485.80a 501.67a 18.59a 19.23a
2 (08/10/06 to 09/28/06) 511.65a 549.30a 19.17b 19.85a
3 (10/12/06 to 11/30/06) 509.84a 515.28a 18.85a 18.88a
4 (12/22/06 to 02/08/07) 545.22a 523.45a 19.62a 19.02a
5 (03/06/07 to 04/24/07) 541.14a 540.68a 19.35a 19.56a
Cumulative average (flocks 1 to 5) 518.73a 526.08a 19.12a 19.31a
a,bMeans between treatment groups without a common superscript are significantly different (P < 0.05).
1Diets: treated = basal diets with coccidiostat, ROX, and GPA; control = basal diets with coccidiostat.
2Placement date of flock to ending date of flock.
3Total white meat (g) = (breast fillet + tenders).
4Total white meat (%) = (total white meat/BW) × 100.
Table 6. Effect of removing growth-promoting antibiotics (GPA) and roxarsone (ROX) on drum, thigh, and back yield 
of broilers at 49 d of age1 
Flock2
Drum (g) Thigh (g) Back (g)
Treated Control Treated Control Treated Control
1 (06/08/06 to 07/27/06) 261.72b 268.07a 307.08a 308.90a 199.58a 202.30a
2 (08/10/06 to 09/28/06) 267.62a 275.78a 304.81a 317.97a 212.73a 233.15a
3 (10/12/06 to 11/30/06) 265.81a 266.71a 316.61a 308.90a 208.20a 213.19a
4 (12/22/06 to 02/08/07) 286.22a 271.70a 320.24a 308.90a 207.29a 206.84a
5 (03/06/07 to 04/24/07) 268.53a 268.53a 323.41a 318.88a 214.10a 212.74a
Cumulative average (flocks 1 to 5) 270.34a 270.34a 314.34a 312.98a 208.65a 213.64a
a,bMeans between treatment groups without a common superscript are significantly different (P < 0.05).
1Diets: treated = basal diets with coccidiostat, ROX, and GPA; control = basal diets with coccidiostat.
2Placement date of flock to ending date of flock.
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ets throughout the study. The cumulative 
average feed conversion and adjusted 
feed conversion were not significantly 
different at 49 d of age.
 3.  Removal of ROX and GPA had no impact 
on coccidiosis lesion scores throughout 
the study.
 4.  Livability percentage was negatively af-
fected by the removal of ROX and GPA 
across the 5 flocks.
 5.  Overall meat yield performance was not 
affected by the removal of these drugs 
from the diets.
 6.  Although the data from this study dem-
onstrated that broilers reared without 
ROX and GPA in a commercial setting 
can perform as well as birds receiving 
prophylactic antimicrobial drugs; these 
results must be interpreted in context.
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